Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ORKAOruka Therapeutics, Inc.

Nasdaq · CIK 0000907654
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts386

Identity from submissions API

NameOruka Therapeutics, Inc.
CIK0000907654
TickersORKA
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN363855489
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone650-606-7910
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • ARCA biopharma, Inc. (2009-01-28T00:00:00.000Z → 2024-08-30T00:00:00.000Z)
  • NUVELO INC (2003-02-04T00:00:00.000Z → 2009-01-27T00:00:00.000Z)
  • HYSEQ INC (1997-07-17T00:00:00.000Z → 2003-01-28T00:00:00.000Z)
Business address
855 OAK GROVE AVE.
SUITE 100
MENLO PARK
CA
94025
CA
Mailing address
855 OAK GROVE AVE.
SUITE 100
MENLO PARK
CA
94025
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1546 filing rows loaded from submissions recent; extra archives: CIK0000907654-submissions-001.json (544 filings, 1997-06-12 to 2009-08-23).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000120 14191
2026-11-20 144 xsl144X01/primary_doc.xml 0001950047-26-011386 000-22873 261579505 33 7484
2026-11-16 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000118 21042
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001897612-26-000718 005-51477 261556525 34 7829
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001493215-26-000198 005-51477 261555658 34 10708
2026-11-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000116 20680
2026-11-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000115 17428
2026-11-12 144 xsl144X01/primary_doc.xml 0001950047-26-011034 000-22873 261547323 33 9123
2026-11-12 144 xsl144X01/primary_doc.xml 0001950047-26-011029 000-22873 261547297 33 5103
2026-11-09 10-Q QUARTERLY REPORT 0001213900-26-117518 000-22873 261535805 34 7359868 1 1
2026-11-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000112 15843
2026-11-02 144 xsl144X01/primary_doc.xml 0001950047-26-010585 000-22873 261513030 33 7460
2026-10-26 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-26-112281 000-22873 261483571 34 18057066 1 1
2026-10-20 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000110 15838
2026-10-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000108 19385
2026-10-15 144 xsl144X01/primary_doc.xml 0001950047-26-010266 000-22873 261463470 33 6721
2026-10-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000106 17619
2026-10-13 144 xsl144X01/primary_doc.xml 0001950047-26-010177 000-22873 261454805 33 8851
2026-10-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000104 12546
2026-10-01 144 xsl144X01/primary_doc.xml 0001950047-26-009940 000-22873 261431642 33 6552
2026-09-21 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000102 5064
2026-09-21 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000100 14197
2026-09-21 144 xsl144X01/primary_doc.xml 0001950047-26-009701 000-22873 261394247 33 8607
2026-09-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000098 19402
2026-09-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000097 19287
2026-09-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000096 5219
2026-09-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000095 5225
2026-09-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000094 5225
2026-09-01 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000088 10931
2026-09-01 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000087 12550
2026-09-01 144 xsl144X01/primary_doc.xml 0001950047-26-008954 000-22873 261351517 33 6481
2026-09-01 144 xsl144X01/primary_doc.xml 0001950047-26-008949 000-22873 261351508 33 5828
2026-08-28 424B5 PROSPECTUS 0001213900-26-095041 333-298488 261340104 33 125448
2026-08-27 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002787 333-298488 261332656 33 2028
2026-08-25 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000084 7388
2026-08-25 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000083 9420
2026-08-24 8-K CURRENT REPORT 5.02,9.01 0001213900-26-093021 000-22873 261310552 34 300230 1 1
2026-08-21 S-3 REGISTRATION STATEMENT 0001213900-26-092612 333-298488 261304969 33 673424 1 1
2026-08-17 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000079 17752
2026-08-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000077 21014
2026-08-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000075 19282
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001231919-26-000934 005-51477 261283209 34 18644
2026-08-14 144 xsl144X01/primary_doc.xml 0001950047-26-008164 000-22873 261282917 33 6040
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000905148-26-003735 005-51477 261281608 34 36407
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001493215-26-000153 005-51477 261276267 34 12852
2026-08-12 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001422849-26-000148 005-51477 261268991 34 7625
2026-08-10 10-Q QUARTERLY REPORT 0001213900-26-087231 000-22873 261258389 34 7252131 1 1
2026-08-10 8-K CURRENT REPORT 2.02,9.01 0001213900-26-086933 000-22873 261256149 34 270627 1 1
2026-07-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000073 17739
2026-07-15 144 xsl144X01/primary_doc.xml 0001950047-26-007123 000-22873 261177706 33 7429
2026-07-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000071 17619
2026-07-13 144 xsl144X01/primary_doc.xml 0001950047-26-007037 000-22873 261171720 33 8125
2026-07-01 144 xsl144X01/primary_doc.xml 0001104659-26-080011 000-22873 261147538 33 5256
2026-07-01 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001104659-26-080010 005-51477 261147532 34 21470
2026-07-01 4 OWNERSHIP DOCUMENT 0001104659-26-080009 18595
2026-07-01 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000069 12577
2026-06-22 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000066 6465
2026-06-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000064 17822
2026-06-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000063 17935
2026-06-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000062 5219
2026-06-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000061 5225
2026-06-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000060 5224
2026-06-12 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000054 7226
2026-06-11 144 xsl144X01/primary_doc.xml 0001950047-26-005932 000-22873 261083391 33 5768
2026-06-04 8-K CURRENT REPORT 5.07 0001213900-26-065294 000-22873 261065172 34 196552 1 1
2026-06-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000052 5585
2026-06-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000051 5594
2026-06-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000050 5616
2026-06-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000049 5604
2026-06-03 4 OWNERSHIP DOCUMENT 0001104659-26-070135 14235
2026-06-01 8-K CURRENT REPORT 8.01,9.01 0001213900-26-063481 000-22873 261050391 34 224551 1 1
2026-05-22 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000043 19539
2026-05-21 144 xsl144X01/primary_doc.xml 0001950047-26-004908 000-22873 261009062 33 5631
2026-05-18 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000041 17618
2026-05-18 144 xsl144X01/primary_doc.xml 0001950047-26-004706 000-22873 26994128 33 7138
2026-05-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000039 15846
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000905148-26-002436 005-51477 26990049 34 36864
2026-05-13 10-Q QUARTERLY REPORT 0001213900-26-055769 000-22873 26973098 34 6503961 1 1
2026-05-04 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001104659-26-055049 005-51477 26939485 34 22364
2026-05-01 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000037 17267
2026-05-01 144 xsl144X01/primary_doc.xml 0001950047-26-003915 000-22873 26933383 33 6710
2026-04-30 8-K CURRENT REPORT 2.02,8.01,9.01 0001213900-26-050249 000-22873 26925682 34 500389 1 1
2026-04-29 424B5 PROSPECTUS SUPPLEMENT 0001213900-26-049372 333-294852 26917490 33 313050
2026-04-27 424B5 PRELIMINARY PROSPECTUS SUPPLEMENT 0001213900-26-048100 333-294852 26902188 33 310778
2026-04-27 424B5 PRELIMINARY PROSPECTUS SUPPLEMENT 0001213900-26-048099 333-294852 26902179 33 454237
2026-04-27 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-26-047743 000-22873 26896608 34 18417583 1 1
2026-04-21 424B7 PROSPECTUS SUPPLEMENT 0001213900-26-046194 333-290715 26879795 33 20680
2026-04-17 ARS ANNUAL REPORT 0001213900-26-045179 000-22873 26871870 34 1822911
2026-04-17 DEFA14A PROXY STATEMENT 0001213900-26-045169 000-22873 26871738 34 4036090
2026-04-17 DEF 14A PROXY STATEMENT 0001213900-26-045159 000-22873 26871638 34 8370703 1 1
2026-04-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000035 16093
2026-04-15 144 xsl144X01/primary_doc.xml 0001950047-26-003530 000-22873 26864742 33 7428
2026-04-10 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001154 333-294852 26856325 33 2027
2026-04-08 CORRESP filename1.htm 0001213900-26-041494 18907
2026-04-07 UPLOAD filename1.pdf 0000000000-26-003492 333-294852 40324
2026-04-02 S-3 REGISTRATION STATEMENT 0001213900-26-039332 333-294852 26833359 33 383384 1 1
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-001923 005-51477 26802585 34 7441
2026-03-17 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000033 5081
2026-03-17 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000032 5057
2026-03-17 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000031 5087
2026-03-17 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000030 17617
2026-03-17 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000029 5086
2026-03-12 S-8 REGISTRATION STATEMENT 0001213900-26-026975 333-294250 26748142 33 174057 1 1
2026-03-12 10-K ANNUAL REPORT 0001213900-26-026929 000-22873 26747557 34 15447859 1 1
2026-03-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000022 10793
2026-02-17 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000020 14331
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493215-26-000040 005-51477 26636742 34 10621
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-000719 005-51477 26629119 34 13369
2026-01-30 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-26-000220 005-51477 26582401 34 7239
2026-01-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000018 7191
2026-01-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000017 7208
2026-01-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000016 7324
2026-01-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000015 7201
2026-01-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000014 7207
2026-01-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000013 4927
2026-01-21 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-26-000779 005-51477 26545997 34 11070
2026-01-16 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000004 14327
2026-01-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-26-000002 12440
2026-01-02 144 xsl144X01/primary_doc.xml 0001950047-26-000069 000-22873 26502824 33 5874
2025-12-19 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-25-000023 17936
2025-12-19 144 xsl144X01/primary_doc.xml 0001950047-25-010551 000-22873 251587817 33 5282
2025-12-11 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-25-000019 5487
2025-12-11 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0000907654-25-000017 9255
2025-12-11 8-K CURRENT REPORT 5.02,9.01 0001213900-25-120676 000-22873 251565098 34 240134 1 1
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001738048-25-000022 005-51477 251488423 34 19059
2025-11-12 10-Q QUARTERLY REPORT 0001213900-25-109182 000-22873 251472491 34 7560229 1 1
2025-11-05 424B3 PROSPECTUS 0001213900-25-106669 333-290715 251454452 33 229946
2025-11-05 424B5 PROSPECTUS 0001213900-25-106667 333-290718 251454446 33 132876
2025-10-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-002889 005-51477 251402022 34 11080
2025-10-14 S-3/A AMENDMENT NO. 1 TO FORM S-3 0001213900-25-098805 333-290715 251392314 33 307242
2025-10-14 S-3/A AMENDMENT NO. 1 TO FORM S-3 0001213900-25-098802 333-290718 251392310 33 385654
2025-10-03 S-3 REGISTRATION STATEMENT 0001213900-25-096198 333-290718 251375076 33 778867 1 1
2025-10-03 S-3 REGISTRATION STATEMENT 0001213900-25-096190 333-290715 251375000 33 492038 1 1
2025-09-24 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000905148-25-003402 005-51477 251339414 34 38307
2025-09-22 424B3 PROSPECTUS SUPPLEMENT 0001213900-25-090131 333-283212 251330410 33 530914
2025-09-22 8-K CURRENT REPORT 1.01,3.02,7.01,9.01 0001213900-25-090129 000-22873 251330397 34 798523 1 1
2025-09-19 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-091774 005-51477 251328125 34 22545
2025-09-19 4 OWNERSHIP DOCUMENT 0001104659-25-091747 13605
2025-08-11 424B3 PROSPECTUS SUPPLEMENT 0001213900-25-074322 333-283212 251202425 33 939642
2025-08-11 10-Q QUARTERLY REPORT 0001213900-25-074281 000-22873 251201893 34 7134506 1 1
2025-07-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-003242 005-51477 251132390 34 11028
2025-07-01 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-012406 5597
2025-07-01 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-012405 12493
2025-07-01 8-K CURRENT REPORT 5.02,9.01 0001213900-25-060352 000-22873 251096201 34 315377 1 1
2025-06-03 4 OWNERSHIP DOCUMENT 0001104659-25-055989 13658
2025-06-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-010826 5460
2025-06-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-010825 5451
2025-06-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-010824 5467
2025-06-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-010822 5449
2025-06-03 8-K CURRENT REPORT 5.07 0001213900-25-050756 000-22873 251019194 34 199425 1 1
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-072013 005-51477 25948797 34 128224
2025-05-14 424B3 PROSPECTUS SUPPLEMENT 0001213900-25-043374 333-283212 25946426 33 893012
2025-05-14 10-Q QUARTERLY REPORT 0001213900-25-043279 000-22873 25945159 34 6813369 1 1
2025-05-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-001776 005-51477 25940683 34 11464
2025-04-18 ARS ANNUAL REPORT 0001213900-25-033326 000-22873 25850281 34 1499001
2025-04-18 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-25-033322 000-22873 25850272 34 1723479
2025-04-18 DEF 14A PROXY STATEMENT 0001213900-25-033316 000-22873 25850257 34 8116372 1 1
2025-03-11 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000640 333-283212 25729824 33 2047
2025-03-10 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-022364 005-51477 25725361 34 24132
2025-03-06 POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 0001213900-25-021251 333-283212 25716364 33 8748841 1 1
2025-03-06 S-8 REGISTRATION STATEMENT 0001213900-25-021200 333-285601 25715617 33 65648
2025-03-06 10-K ANNUAL REPORT 0001213900-25-021165 000-22873 25715110 34 12618504 1 1
2025-02-27 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-005913 005-51477 25681634 34 25340
2025-02-27 4 xslF345X05/form4-02272025_110244.xml 0001415889-25-005908 25820
2025-02-27 3 xslF345X02/form3-02272025_110208.xml 0001415889-25-005906 18958
2025-02-05 8-K CURRENT REPORT 1.01 0001213900-25-010525 000-22873 25593122 34 204099 1 1
2025-01-24 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-001089 5526
2025-01-24 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-001088 5577
2025-01-24 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-001087 5571
2025-01-24 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-001085 5571
2024-12-19 8-K CURRENT REPORT 1.01 0001213900-24-110303 000-22873 241560969 34 208027 1 1
2024-11-26 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-11-26 16:15:00 9999999995-24-003588 333-283212 241506123 33 2048
2024-11-22 CORRESP filename1.htm 0001213900-24-101587 12060
2024-11-22 UPLOAD filename1.pdf 0000000000-24-012994 333-283212 40401
2024-11-21 SC 13D/A AMENDMENT NO. 2 TO SCHEDULE 13D 0001213900-24-101117 005-51477 241485918 34 125539
2024-11-21 4 xslF345X05/ownership.xml 0001213900-24-101116 14983
2024-11-18 8-K CURRENT REPORT 5.07 0001213900-24-099645 000-22873 241471562 34 199554 1 1
2024-11-14 SC 13G/A d11530393_13g-a.htm 0000919574-24-006793 005-51477 241465266 34 162509
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-119331 005-51477 241464784 34 178631
2024-11-14 S-8 REGISTRATION STATEMENT 0001213900-24-098574 333-283243 241464394 33 205573
2024-11-14 8-K CURRENT REPORT 8.01,9.01 0001213900-24-098530 000-22873 241463883 34 269258 1 1
2024-11-14 SC 13G/A oruka13ga1-11142024.htm 0001013594-24-000956 005-51477 241459161 34 141457
2024-11-14 SC 13G/A JANUS CLOSEOUT 0001274173-24-000089 005-51477 241457999 34 12921
2024-11-14 S-1 REGISTRATION STATEMENT 0001213900-24-097737 333-283212 241456990 33 15137904 1 1
2024-11-13 10-Q QUARTERLY REPORT 0001213900-24-097443 000-22873 241453876 34 6241428 1 1
2024-10-22 SC 13D/A p24-3033sc13da.htm 0000902664-24-005943 005-51477 241386475 34 81243
2024-10-18 DEF 14A DEF 14A 0001140361-24-043698 000-22873 241380856 34 1742014
2024-10-07 PRE 14A PRE 14A 0001140361-24-042965 000-22873 241357837 34 1739827
2024-10-07 SC 13G filing.txt 0000315066-24-002024 005-51477 241356667 34 8438
2024-10-04 8-K CURRENT REPORT 5.02,9.01 0001213900-24-085543 000-22873 241354944 34 378427 1 1
2024-09-13 SC 13D/A AMENDMENT NO. 1 TO SCHEDULE 13D 0001213900-24-078635 005-51477 241298450 34 134023
2024-09-13 4 xslF345X05/ownership.xml 0001213900-24-078633 15361
2024-09-13 8-K CURRENT REPORT 1.01,3.02,5.03,7.01,9.01 0001213900-24-078549 000-22873 241297682 34 1132194 1 1
2024-09-06 SC 13D SCHEDULE 13D 0001213900-24-076599 005-51477 241285191 34 260732
2024-09-06 3 xslF345X02/ownership.xml 0001213900-24-076598 22948
2024-09-06 3 xslF345X02/ownership.xml 0001213900-24-076596 12437
2024-09-06 3 xslF345X02/ownership.xml 0001213900-24-076593 11522
2024-09-06 3 xslF345X02/ownership.xml 0001213900-24-076591 11838
2024-09-06 3 xslF345X02/ownership.xml 0001213900-24-076589 11639
2024-09-06 3 xslF345X02/ownership.xml 0001213900-24-076588 11701
2024-09-06 3 xslF345X02/ownership.xml 0001213900-24-076585 11722
2024-09-06 3 xslF345X02/ownership.xml 0001213900-24-076582 11693
2024-09-06 3 xslF345X02/ownership.xml 0001213900-24-076578 12375
2024-09-05 8-K CURRENT REPORT 1.01,2.01,2.02,3.03,4.01,5.01,5.02,5.03,5.05,5.06,7.01,9.01 0001213900-24-076184 000-22873 241282218 34 2261549 1 1
2024-08-30 4 PRIMARY DOCUMENT 0001937147-24-000007 11174
2024-08-27 425 CURRENT REPORT 0001213900-24-072685 000-22873 241242887 34 54411
2024-08-27 8-K CURRENT REPORT 8.01,9.01 0001213900-24-072683 000-22873 241242883 34 241612 1 1
2024-08-23 8-K CURRENT REPORT 5.07,8.01,9.01 0001213900-24-072251 000-22873 241236781 34 277566 1 1
2024-08-20 4 FORM 4 0001437749-24-027344 8716
2024-08-16 425 CURRENT REPORT 0001213900-24-070266 000-22873 241217049 34 70896
2024-08-16 8-K CURRENT REPORT 8.01,9.01 0001213900-24-070263 000-22873 241217016 34 260731 1 1
2024-08-15 425 CURRENT REPORT 0001213900-24-069667 000-22873 241212649 34 108084
2024-08-15 8-K CURRENT REPORT 1.01,9.01 0001213900-24-069662 000-22873 241212620 34 306123 1 1
2024-08-09 425 FORM 425 0001213900-24-066829 000-22873 241190500 34 27009472
2024-08-01 425 425 0000950170-24-089337 000-22873 241167211 34 173565
2024-08-01 8-K 8-K 2.02,9.01 0000950170-24-089329 000-22873 241167133 34 306017 1 1
2024-08-01 424B3 424B3 0000950170-24-089279 333-279387 241166717 33 1245107
2024-08-01 10-Q 10-Q 0000950170-24-089246 000-22873 241166534 34 4577607 1 1
2024-07-26 SEC STAFF LETTER filename1.pdf 9999999997-24-003394 63943
2024-07-26 4 FORM 4 0001437749-24-023533 11757
2024-07-24 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2024-07-24 16:00:00 9999999995-24-002258 333-279387 241139606 33 1951
2024-07-24 ARS FORM ARS 0001013762-24-000756 000-22873 241138755 34 3123132
2024-07-23 CORRESP filename1.htm 0001213900-24-063687 6927
2024-07-22 CORRESP filename1.htm 0001013762-24-000532 41449
2024-07-22 S-4/A REGISTRATION STATEMENT 0001013762-24-000530 333-279387 241132294 33 33865208 1 1
2024-07-16 UPLOAD filename1.pdf 0000000000-24-008082 333-279387 43254
2024-07-12 SEC STAFF LETTER filename1.pdf 9999999997-24-003613 66181
2024-07-12 4 FORM 4 0001437749-24-022708 19375
2024-07-12 3 FORM 3 0001437749-24-022706 18567
2024-07-09 S-4/A REGISTRATION STATEMENT 0001213900-24-060183 333-279387 241108193 33 26244571 1 1
2024-07-09 CORRESP filename1.htm 0001213900-24-060184 20968
2024-07-09 425 CURRENT REPORT 0001213900-24-060159 000-22873 241108025 34 191733
2024-07-09 8-K CURRENT REPORT 1.01,9.01 0001213900-24-060156 000-22873 241107999 34 408613 1 1
2024-07-05 SC 13G/A JHG PLC (JHBIF) OWNS 10% 0001274173-24-000071 005-51477 241103080 34 13177
2024-07-03 UPLOAD filename1.pdf 0000000000-24-007602 333-279387 43681
2024-06-18 CORRESP filename1.htm 0001213900-24-053908 58062
2024-06-18 S-4/A REGISTRATION STATEMENT 0001213900-24-053881 333-279387 241053031 33 26738782 1 1
2024-06-11 UPLOAD filename1.pdf 0000000000-24-006675 333-279387 61425
2024-06-06 425 FORM 425 0001213900-24-050402 000-22873 241026110 34 20249764
2024-05-14 S-4 REGISTRATION STATEMENT 0001213900-24-042529 333-279387 24941169 33 26983994 1 1
2024-04-29 SC 13G SC 13G 0001104659-24-054266 005-51477 24893461 34 190680
2024-04-25 425 425 0000950170-24-048369 000-22873 24876788 34 150845
2024-04-25 8-K 8-K 2.02,9.01 0000950170-24-048364 000-22873 24876751 34 283613 1 1
2024-04-25 10-Q 10-Q 0000950170-24-048329 000-22873 24876502 34 4188544 1 1
2024-04-23 8-K 8-K 5.02,9.01 0000950170-24-046918 000-22873 24865086 34 207746 1 1
2024-04-15 SC 13G arca13g-04152024.htm 0001013594-24-000372 005-51477 24845610 34 144204
2024-04-11 SC 13G JANUS HENDERSON GROUP PLC OWNS 7.4% OF ARCA BIOPHARMA, INC 0001274173-24-000067 005-51477 24837330 34 13219
2024-04-09 SC 13G d11021961_13-g.htm 0000919574-24-002436 005-51477 24834026 34 167899
2024-04-05 SC 13G/A SC 13G/A 0001193125-24-088757 005-51477 24827843 34 84121
2024-04-05 SC 13D ARCA BIOPHARMA, INC. 0000902664-24-002769 005-51477 24826460 34 86063
2024-04-04 8-K 8-K 5.02,9.01 0000950170-24-041846 000-22873 24823499 34 429228 1 1
2024-04-03 425 425 0001193125-24-085440 000-22873 24816858 34 4929158
2024-04-03 8-K 8-K 1.01,3.02,5.01,5.02,7.01,9.01 0001193125-24-085437 000-22873 24816849 34 5337327 1 1
2024-03-22 8-K 8-K 1.01,9.01 0000950170-24-035373 000-22873 24775510 34 184208 1 1
2024-02-07 SC 13G/A arca13g020724.htm 0001616824-24-000034 005-51477 24603453 34 60147
2024-02-06 8-K 8-K 5.02,9.01 0000950170-24-011737 000-22873 24600441 34 152950 1 1
2024-02-01 8-K 8-K 2.02,9.01 0000950170-24-009852 000-22873 24587510 34 253208 1 1
2024-02-01 10-K 10-K 0000950170-24-009809 000-22873 24587126 34 6562239 1 1
2024-01-31 4 PRIMARY DOCUMENT 0001922140-24-000001 6421
2024-01-31 4 FORM 4 SUBMISSION 0001209191-24-002481 5958
2024-01-31 4 FORM 4 SUBMISSION 0001209191-24-002480 6473
2024-01-31 4 FORM 4 SUBMISSION 0001209191-24-002479 5938
2024-01-31 4 FORM 4 SUBMISSION 0001209191-24-002478 6759
2024-01-31 4 FORM 4 SUBMISSION 0001209191-24-002477 6025
2024-01-31 4 FORM 4 SUBMISSION 0001209191-24-002476 6003
2024-01-31 8-K 8-K 5.02,5.07,9.01 0000950170-24-009397 000-22873 24583079 34 178094 1 1
2023-12-19 ARS ARS 0000950170-23-071506 000-22873 231497624 34 479955
2023-12-19 DEFA14A DEFA14A 0000950170-23-071499 000-22873 231497543 34 2116913
2023-12-19 DEF 14A DEF 14A 0000950170-23-071494 000-22873 231497471 34 3919321 1 1
2023-12-05 8-K 8-K 5.08,9.01 0000950170-23-068189 000-22873 231466931 34 156072 1 1
2023-12-04 8-K 8-K 5.02,9.01 0000950170-23-067790 000-22873 231463729 34 218505 1 1
2023-10-18 8-K 8-K 2.02,9.01 0000950170-23-053987 000-22873 231332573 34 332463 1 1
2023-10-18 10-Q 10-Q 0000950170-23-053972 000-22873 231332415 34 4570612 1 1
2023-09-11 SC 13G SC 13G 0001193125-23-232441 005-51477 231247723 34 77585
2023-07-21 8-K 8-K 2.02,9.01 0000950170-23-033845 000-22873 231102927 34 359130 1 1
2023-07-21 10-Q 10-Q 0000950170-23-033834 000-22873 231102698 34 4878635 1 1
2023-04-24 8-K 8-K 2.02,9.01 0000950170-23-014115 000-22873 23840551 34 301551 1 1
2023-04-24 10-Q 10-Q 0000950170-23-014091 000-22873 23840292 34 4594396 1 1
2023-02-24 8-K 8-K 2.02,9.01 0000950170-23-004387 000-22873 23667902 34 302325 1 1
2023-02-24 10-K 10-K 0000950170-23-004379 000-22873 23667512 34 7928639 1 1
2023-02-13 8-K 8-K 5.02,9.01 0000950170-23-002622 000-22873 23618993 34 173519 1 1
2023-02-08 SC 13G/A NONE 0001567619-23-002070 005-51477 23598704 34 66941
2022-12-19 4 OWNERSHIP DOCUMENT 0000921895-22-003245 14931
2022-12-19 4 FORM 4 SUBMISSION 0001209191-22-061923 9099
2022-12-19 4 FORM 4 SUBMISSION 0001209191-22-061919 9575
2022-12-19 4 FORM 4 SUBMISSION 0001209191-22-061908 9122
2022-12-19 4 FORM 4 SUBMISSION 0001209191-22-061911 9055
2022-12-19 4 FORM 4 SUBMISSION 0001209191-22-061901 9866
2022-12-19 4 FORM 4 SUBMISSION 0001209191-22-061897 9063
2022-12-19 3 FORM 3 SUBMISSION 0001209191-22-061894 6397
2022-12-19 8-K 8-K 5.02,5.07,9.01 0000950170-22-026739 000-22873 221471257 34 310630 1 1
2022-12-09 4 FORM 4 SUBMISSION 0001209191-22-060498 8807
2022-12-09 4 FORM 4 SUBMISSION 0001209191-22-060497 8751
2022-12-09 8-K 8-K 5.02,9.01 0000950170-22-026298 000-22873 221454963 34 293043 1 1
2022-11-03 DEFA14A DEFA14A 0001564590-22-036619 000-22873 221358364 34 1298761
2022-11-03 DEF 14A DEF 14A 0001564590-22-036613 000-22873 221358214 34 2617573
2022-10-28 8-K 8-K 2.02,9.01 0001564590-22-035701 000-22873 221342299 34 582761 1 1
2022-10-28 10-Q 10-Q 0001564590-22-035668 000-22873 221341889 34 4219417 1 1
2022-10-20 8-K 8-K 5.08,9.01 0001564590-22-034773 000-22873 221321697 34 164221 1 1
2022-08-02 8-K 8-K 2.02,9.01 0001564590-22-027494 000-22873 221129171 34 582429 1 1
2022-08-02 10-Q 10-Q 0001564590-22-027468 000-22873 221128662 34 4182582 1 1
2022-07-08 4 OWNERSHIP DOCUMENT 0000921895-22-002200 12623
2022-07-08 3 OWNERSHIP DOCUMENT 0000921895-22-002199 6678
2022-07-08 SC 13D/A AMENDMENT NO. 6 TO THE SCHEDULE 13D 0000921895-22-002198 005-51477 221074721 34 96592
2022-06-21 4 OWNERSHIP DOCUMENT 0000921895-22-002055 9557
2022-06-21 3 OWNERSHIP DOCUMENT 0000921895-22-002054 6110
2022-06-21 SC 13D/A AMENDMENT NO. 5 TO THE SCHEDULE 13D 0000921895-22-002046 005-51477 221028508 34 72722
2022-06-21 8-K 8-K 1.01,5.02,9.01 0001564590-22-023734 000-22873 221027608 34 591268 1 1
2022-05-27 SC 13D/A AMENDMENT NO. 4 TO THE SCHEDULE 13D 0000921895-22-001819 005-51477 22978369 34 77466
2022-05-25 4 OWNERSHIP DOCUMENT 0000921895-22-001792 12934
2022-05-20 4 OWNERSHIP DOCUMENT 0000921895-22-001755 10835
2022-05-16 4 OWNERSHIP DOCUMENT 0000921895-22-001688 13468
2022-05-11 4 OWNERSHIP DOCUMENT 0000921895-22-001599 10839
2022-05-11 SC 13D/A AMENDMENT NO. 3 TO THE SCHEDULE 13D 0000921895-22-001583 005-51477 22914515 34 81998
2022-05-09 4 OWNERSHIP DOCUMENT 0000921895-22-001519 13468
2022-05-05 8-K 8-K 8.01,9.01 0001564590-22-018272 000-22873 22896650 34 454234 1 1
2022-05-02 4 OWNERSHIP DOCUMENT 0000921895-22-001438 13409
2022-05-02 8-K 8-K 2.02,9.01 0001564590-22-017065 000-22873 22882319 34 528162 1 1
2022-05-02 10-Q 10-Q 0001564590-22-017043 000-22873 22881923 34 3942138 1 1
2022-04-27 4 OWNERSHIP DOCUMENT 0000921895-22-001390 10702
2022-04-20 4 OWNERSHIP DOCUMENT 0000921895-22-001318 10699
2022-04-18 8-K 8-K 8.01,9.01 0001564590-22-014649 000-22873 22832599 34 454940 1 1
2022-04-14 4 OWNERSHIP DOCUMENT 0000921895-22-001257 7942
2022-04-14 SC 13D/A AMENDMENT NO. 2 TO THE SCHEDULE 13D 0000921895-22-001251 005-51477 22827767 34 76698
2022-04-12 4 OWNERSHIP DOCUMENT 0000921895-22-001225 11600
2022-04-07 4 OWNERSHIP DOCUMENT 0000921895-22-001178 12134
2022-04-07 4/A OWNERSHIP DOCUMENT 0000921895-22-001177 8185
2022-04-07 3/A OWNERSHIP DOCUMENT 0000921895-22-001176 6727
2022-04-04 4 OWNERSHIP DOCUMENT 0000921895-22-001091 6456
2022-04-04 3 OWNERSHIP DOCUMENT 0000921895-22-001090 4997
2022-04-04 SC 13D/A AMENDMENT NO. 1 TO THE SCHEDULE 13D 0000921895-22-001068 005-51477 22803626 34 73023
2022-03-31 8-K 8-K 8.01,9.01 0001564590-22-013022 000-22873 22793280 34 503318 1 1
2022-03-28 SC 13D THE SCHEDULE 13D 0000921895-22-000996 005-51477 22775722 34 88089
2022-03-18 424B5 424B5 0001564590-22-011064 333-254585 22752727 33 1111326
2022-03-14 8-K 8-K 2.02,9.01 0001564590-22-010094 000-22873 22736967 34 543977 1 1
2022-03-14 10-K 10-K 0001564590-22-010075 000-22873 22736598 34 6661393 1 1
2022-01-27 SC 13G NONE 0001567619-22-001853 005-51477 22563066 34 66947
2021-12-16 4 FORM 4 SUBMISSION 0001209191-21-069964 6746
2021-12-16 4 FORM 4 SUBMISSION 0001209191-21-069963 10135
2021-12-16 4 FORM 4 SUBMISSION 0001209191-21-069962 6067
2021-12-16 4 FORM 4 SUBMISSION 0001209191-21-069960 11432
2021-12-16 8-K 8-K 5.02 0001564590-21-060582 000-22873 211498136 34 170675 1 1
2021-12-02 8-K 8-K 8.01,9.01 0001564590-21-059167 000-22873 211466798 34 467003 1 1
2021-11-23 4 FORM 4 SUBMISSION 0001209191-21-066497 8588
2021-11-02 8-K 8-K 2.02,9.01 0001564590-21-053578 000-22873 211371836 34 612092 1 1
2021-11-02 10-Q 10-Q 0001564590-21-053546 000-22873 211371230 34 4411060 1 1
2021-10-28 8-K 8-K 8.01,9.01 0001564590-21-052696 000-22873 211358954 34 470155 1 1
2021-09-16 8-K 8-K 8.01,9.01 0001564590-21-048130 000-22873 211258103 34 475038 1 1
2021-08-09 8-K 8-K 8.01,9.01 0001564590-21-042647 000-22873 211156688 34 462027 1 1
2021-08-04 8-K 8-K 2.02,9.01 0001564590-21-040864 000-22873 211144456 34 617359 1 1
2021-08-04 10-Q 10-Q 0001564590-21-040795 000-22873 211144010 34 4521254 1 1
2021-07-28 8-K 8-K 8.01,9.01 0001564590-21-038629 000-22873 211122731 34 477436 1 1
2021-07-13 8-K 8-K 8.01,9.01 0001564590-21-036365 000-22873 211086838 34 474176 1 1
2021-07-09 8-K 8-K 5.07 0001564590-21-036172 000-22873 211083009 34 183604 1 1
2021-07-07 8-K 8-K 1.01,9.01 0001564590-21-035989 000-22873 211077576 34 471019 1 1
2021-06-28 DEFA14A DEFA14A 0001564590-21-034800 000-22873 211053746 34 32281
2021-06-28 8-K 8-K 8.01 0001564590-21-034798 000-22873 211053735 34 166385 1 1
2021-06-28 8-K 8-K 5.03,9.01 0001564590-21-034792 000-22873 211053555 34 271919 1 1
2021-06-10 8-K 8-K 8.01 0001564590-21-032461 000-22873 211008431 34 30708
2021-05-13 4 FORM 4 SUBMISSION 0001209191-21-032381 8702
2021-05-11 3 FORM 3 SUBMISSION 0001209191-21-031693 8566
2021-05-11 8-K 8-K 2.02,9.01 0001564590-21-026582 000-22873 21911733 34 151331
2021-05-11 10-Q 10-Q 0001564590-21-026534 000-22873 21911260 34 3844765 1
2021-05-06 4 FORM 4 SUBMISSION 0001209191-21-030629 5290
2021-05-03 8-K 8-K 5.02,9.01 0001564590-21-022863 000-22873 21884652 34 75169
2021-04-21 DEFA14A DEFA14A 0001564590-21-019820 000-22873 21841678 34 1540165
2021-04-21 DEF 14A DEF 14A 0001564590-21-019817 000-22873 21841648 34 2453345
2021-04-06 424B5 424B5 0001564590-21-017827 333-254585 21809537 33 1104972
2021-04-06 8-K 8-K 1.01,5.08,9.01 0001564590-21-017811 000-22873 21809314 34 133148
2021-04-02 RW RW 0001193125-21-105226 333-236667 21802751 NE 9455
2021-03-30 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-03-30 16:00:00 9999999995-21-001215 333-254585 21789617 33 1901
2021-03-26 CORRESP filename1.htm 0001193125-21-097029 6923
2021-03-26 UPLOAD filename1.pdf 0000000000-21-003674 40401
2021-03-22 S-3 S-3 0001564590-21-014608 333-254585 21762021 33 836749
2021-03-18 8-K 8-K 2.02,9.01 0001564590-21-014184 000-22873 21754872 34 148662
2021-03-18 10-K 10-K 0001564590-21-014148 000-22873 21754388 34 5691236 1
2021-02-10 SC 13G/A abio-13g_20201231.txt 0001037389-21-000052 005-51477 21612919 34 13513
2021-02-10 SC 13G/A AMENDMENT TO FORM SC 13G 0001387131-21-001964 005-51477 21609896 34 122697
2021-02-02 8-K 8-K 5.02 0001564590-21-003874 000-22873 21582732 34 39056
2021-01-13 4 FORM 4 SUBMISSION 0001209191-21-003472 5709
2021-01-13 4 FORM 4 SUBMISSION 0001209191-21-003471 5753
2021-01-13 4 FORM 4 SUBMISSION 0001209191-21-003470 5776
2021-01-13 4 FORM 4 SUBMISSION 0001209191-21-003469 6224
2021-01-13 4 FORM 4 SUBMISSION 0001209191-21-003468 6510
2021-01-06 SC 13G/A SABBY 13G-A ABIO 1.06.21 0001535610-21-000037 005-51477 21509653 34 13261
2020-12-23 4 FORM 4 SUBMISSION 0001209191-20-065028 6732
2020-12-23 8-K 8-K 5.02,9.01 0001564590-20-058225 000-22873 201412431 34 486033
2020-12-23 4 FORM 4 SUBMISSION 0001209191-20-065003 6733
2020-12-23 4 FORM 4 SUBMISSION 0001209191-20-065002 8048
2020-12-23 4 FORM 4 SUBMISSION 0001209191-20-065001 6077
2020-12-21 4 FORM 4 SUBMISSION 0001209191-20-064624 5294
2020-12-17 S-8 S-8 0001564590-20-057466 333-251424 201396486 33 199189
2020-12-15 8-K 8-K 8.01,9.01 0001564590-20-057156 000-22873 201389765 34 61296
2020-12-10 8-K 8-K 5.02,5.07,9.01 0001564590-20-056751 000-22873 201381396 34 235442
2020-12-09 DEFA14A DEFA14A 0001564590-20-056585 000-22873 201378692 34 46144
2020-11-23 8-K 8-K 8.01,9.01 0001564590-20-054891 000-22873 201337968 34 79448
2020-11-02 10-Q 10-Q 0001564590-20-049656 000-22873 201280677 34 3789616 1
2020-11-02 8-K 8-K 2.02,9.01 0001564590-20-049634 000-22873 201280492 34 216039
2020-10-28 DEFA14A DEFA14A 0001564590-20-048349 000-22873 201268849 34 226783
2020-10-28 DEF 14A DEF 14A 0001564590-20-048346 000-22873 201268823 34 1094712

Latest XBRL company facts

One latest value per concept from companyfacts (386 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 67.82M 2026-10-31 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
dei EntityPublicFloat Entity Public Float USD 371.50M 2025-06-30 2025 FY 10-K 2026-03-12 0001213900-26-026929
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 5.41M 2025-01-01 2025-12-31 DEF 14A 2026-04-17 0001213900-26-045159
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.34M 2025-01-01 2025-12-31 DEF 14A 2026-04-17 0001213900-26-045159
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 106.57 2025-01-01 2025-12-31 DEF 14A 2026-04-17 0001213900-26-045159
ffd NetFeeAmt NetFeeAmt USD 50,410.55 2026-08-21 S-3 2026-08-21 0001213900-26-092612
ffd TtlFeeAmt TtlFeeAmt USD 50,410.55 2026-08-21 S-3 2026-08-21 0001213900-26-092612
ffd TtlOfferingAmt TtlOfferingAmt USD 1.00B 2026-08-21 S-3 2026-08-21 0001213900-26-092612
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-21 S-3 2026-08-21 0001213900-26-092612
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-08-21 S-3 2026-08-21 0001213900-26-092612
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 3.80M 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097443
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 571,000 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-089246
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 14.38M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 3.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap AccretionExpense Accretion Expense USD 152,000 2001-12-18 2014-03-31 2014 Q1 10-Q 2014-05-13 0001564590-14-002121
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 4.58M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 16.52M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 266,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 218,000 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-089246
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -5.04M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.51B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 225.99M 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-089246
us-gaap AdjustmentForAmortization Amortization USD 329,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004882
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 11,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-22 0001564590-18-006566
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 9.13M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 20.50M 2024-02-07 2024-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 10.06M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 23.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap AmortizationOfDeferredCharges Amortization of Deferred Charges USD 189,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-17 0001564590-16-014989
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 8.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqft 5,200 2020-08-29 2024 Q2 10-Q 2024-08-01 0000950170-24-089246
us-gaap Assets Assets USD 1.23B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap AssetsCurrent Assets, Current USD 941.49M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 1.20B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 6,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 5.05M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 1.21B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss), Net of Tax (Deprecated 2018-01-31) USD 2,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011830
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 3.05M 2017-12-31 2017 FY 10-K 2018-03-22 0001564590-18-006566
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 3.05M 2017-12-31 2017 FY 10-K 2018-03-22 0001564590-18-006566
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 1.20B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 3.05M 2017-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004882
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 2.35M 2016-12-31 2017 FY 10-K 2018-03-22 0001564590-18-006566
us-gaap BusinessAcquisitionCostOfAcquiredEntityPurchasePrice Business Acquisition, Cost of Acquired Entity, Purchase Price (Deprecated 2013-01-31) USD 11.90M 2009-01-27 2013 Q2 10-Q 2013-08-13 0001564590-13-000333
us-gaap BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet Business Acquisition, Purchase Price Allocation, Assets Acquired (Liabilities Assumed), Net (Deprecated 2013-01-31) USD 37.20M 2009-01-27 2013 Q2 10-Q 2013-08-13 0001564590-13-000333
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentAssetsCashAndCashEquivalents Business Acquisition, Purchase Price Allocation, Current Assets, Cash and Cash Equivalents (Deprecated 2013-01-31) USD 45.50M 2009-01-27 2013 Q2 10-Q 2013-08-13 0001564590-13-000333
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 5.47M 2001-12-18 2014-03-31 2014 Q1 10-Q 2014-05-13 0001564590-14-002121
us-gaap BusinessCombinationBargainPurchaseGainRecognizedAmount Business Combination, Bargain Purchase, Gain Recognized, Amount USD 25.28M 2001-12-18 2014-03-31 2014 Q1 10-Q 2014-05-13 0001564590-14-002121
us-gaap BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable Business Combination, Consideration Transferred, Equity Interests Issued and Issuable USD 11.90M 2009-01-01 2009-01-27 2014 Q1 10-Q 2014-05-13 0001564590-14-002121
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents USD 4.94M 2024-08-29 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other USD 114,000 2024-08-29 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities USD 54,000 2024-08-29 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net USD 5.00M 2024-08-29 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 2,000 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-10-28 0001564590-22-035668
us-gaap Cash Cash USD 39.00M 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097443
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 30.39M 2001-12-18 2014-03-31 2014 Q1 10-Q 2014-05-13 0001564590-14-002121
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 191.52M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 3.36M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-01 0001564590-19-027966
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 191.52M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 144.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -4.15M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-089246
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 188.66M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/Unit 1.6 2013-06-04 2013 Q2 10-Q 2013-08-13 0001564590-13-000333
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 315,356 2012-12-31 2012 FY 10-K 2013-03-21 0001193125-13-119763
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 135,862 2019-12-31 2019 FY 10-K 2020-02-18 0001564590-20-005032
us-gaap ClassOfWarrantOrRightUnissued Class of Warrant or Right, Unissued shares 9.66M 2024-12-31 2024 FY 10-K 2025-03-06 0001213900-25-021165
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 28.34M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap CommonStockIncludingAdditionalPaidInCapital Common Stock, Including Additional Paid in Capital (Deprecated 2013-01-31) USD 325,000 2012-10-25 2012 Q3 10-Q 2012-11-13 0001193125-12-467759
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 545.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 67.23M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 67.23M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap CommonStockSharesSubscribedButUnissued Common Stock, Shares Subscribed but Unissued shares 825,184 2012-10-22 2012 Q3 10-Q 2012-11-13 0001193125-12-467759
us-gaap CommonStockValue Common Stock, Value, Issued USD 67,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -128.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure USD 0 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-11 0001564590-15-007020
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 52.83M 2024-02-06 2024-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 2.72M 2024-02-06 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097443
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 2.72M 2024-02-06 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097443
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 100 2013-06-04 2013 Q2 10-Q 2013-08-13 0001564590-13-000333
us-gaap CostsAndExpenses Costs and Expenses USD 5.46M 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-11 0001564590-15-007020
us-gaap CostsAndExpensesRelatedParty Costs and Expenses, Related Party USD 1.47M 2024-02-06 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097443
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 911,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap DebtInstrumentConvertibleInterestExpense Debt Instrument, Convertible, Interest Expense (Deprecated 2013-01-31) USD 163,000 2001-12-17 2011-06-30 2011 Q2 10-Q 2011-08-15 0001193125-11-223373
us-gaap DebtLongtermAndShorttermCombinedAmount Debt, Long-term and Short-term, Combined Amount USD 0 2023-12-31 2023 FY 10-K 2024-02-01 0000950170-24-009809
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 1.16B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 5.05M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 1.16B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 5.05M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 482,000 2011-06-30 2011 Q2 10-Q 2011-08-15 0001193125-11-223373
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 424,000 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap DeferredRentCredit Deferred Rent Credit USD 3,000 2013-06-30 2013 Q2 10-Q 2013-08-13 0001564590-13-000333
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 16,000 2012-12-31 2013 FY 10-K 2014-03-20 0001564590-14-000934
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 20,000 2017-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004882
us-gaap DeferredTaxAssetsCharitableContributionCarryforwards Deferred Tax Assets, Charitable Contribution Carryforwards USD 371,000 2023-12-31 2023 FY 10-K 2024-02-01 0000950170-24-009809
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 2.94M 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 49.14M 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap DeferredTaxAssetsGrossCurrent Deferred Tax Assets, Gross, Current USD 25,000 2014-12-31 2014 FY 10-K 2015-03-19 0001564590-15-001840
us-gaap DeferredTaxAssetsGrossNoncurrent Deferred Tax Assets, Gross, Noncurrent USD 48.62M 2015-12-31 2015 FY 10-K 2016-03-17 0001564590-16-014989
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 25.07M 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2023-12-31 2023 FY 10-K 2024-02-01 0000950170-24-009809
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 63,000 2023-12-31 2023 FY 10-K 2024-02-01 0000950170-24-009809
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 0 2014-12-31 2014 FY 10-K 2015-03-19 0001564590-15-001840
us-gaap DeferredTaxAssetsNetNoncurrent Deferred Tax Assets, Net of Valuation Allowance, Noncurrent USD 0 2015-12-31 2015 FY 10-K 2016-03-17 0001564590-16-014989
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 6.40M 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration USD 51.19M 2023-12-31 2023 FY 10-K 2024-02-01 0000950170-24-009809
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 9,000 2019-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014148
us-gaap DeferredTaxAssetsOtherLossCarryforwards Deferred Tax Assets, Other Loss Carryforwards USD 10.80M 2024-12-31 2024 FY 10-K 2025-03-06 0001213900-25-021165
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 5,000 2020-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014148
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 5.37M 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 7,000 2023-12-31 2023 FY 10-K 2024-02-01 0000950170-24-009809
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Compensated Absences USD 35,000 2016-12-31 2016 FY 10-K 2017-03-21 0001564590-17-004897
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 7.83M 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 1.08M 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 48.72M 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap DeferredTaxAssetsValuationAllowanceCurrent Deferred Tax Assets, Valuation Allowance, Current USD 25,000 2014-12-31 2014 FY 10-K 2015-03-19 0001564590-15-001840
us-gaap DeferredTaxAssetsValuationAllowanceNoncurrent Deferred Tax Assets, Valuation Allowance, Noncurrent USD 48.62M 2015-12-31 2015 FY 10-K 2016-03-17 0001564590-16-014989
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 2,000 2023-12-31 2023 FY 10-K 2024-02-01 0000950170-24-009809
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 56,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-01 0000950170-24-009809
us-gaap Depreciation Depreciation USD 135,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 6,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-089246
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 1.80M 2002-01-01 2013-12-31 2013 FY 10-K 2014-03-20 0001564590-14-000934
us-gaap DilutiveSecurities Dilutive Securities, Effect on Basic Earnings Per Share USD 762,000 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-21 0001193125-13-119763
us-gaap DividendsPreferredStockStock Dividends, Preferred Stock, Stock USD -781,000 2009-01-01 2009-12-31 2014 Q1 10-Q 2014-05-13 0001564590-14-002121
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 324,000 2023-03-31 2023 Q1 10-Q 2023-04-24 0000950170-23-014091
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.85 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-11 0001213900-25-074281
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.23 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-02 0001564590-22-017043
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.85 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-11 0001213900-25-074281
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.221 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.002 2024-02-06 2024-12-31 2024 FY 10-K 2025-03-06 0001213900-25-021165
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.009 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure 0.01 2024-02-06 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097443
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.02 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 9,000 2024-02-06 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097443
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 109,000 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-089246
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 111.10M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 529,000 2013-12-31 2013 FY 10-K 2014-03-20 0001564590-14-000934
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 701,000 2013-12-31 2013 FY 10-K 2014-03-20 0001564590-14-000934
us-gaap ExcessTaxBenefitFromShareBasedCompensationOperatingActivities Excess Tax Benefit from Share-based Compensation, Operating Activities USD 0 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-22 0001564590-18-006566
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2012-12-31 2012 FY 10-K 2013-03-21 0001193125-13-119763
us-gaap FairValueDisclosureOffbalanceSheetRisksAmountAsset Fair Value Disclosure, Off-balance Sheet Risks, Amount, Asset USD 0 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-089246
us-gaap FederalDepositInsuranceCorporationPremiumExpense Federal Deposit Insurance Corporation Premium Expense USD 250,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -5,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-02-01 0000950170-24-009809
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 385,000 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-21 0001193125-13-119763
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 22.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 6.00M 2001-12-18 2014-03-31 2014 Q1 10-Q 2014-05-13 0001564590-14-002121
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 125,000 2001-12-18 2014-03-31 2014 Q1 10-Q 2014-05-13 0001564590-14-002121
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -4.32M 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-21 0001193125-13-119763
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -105.43M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -105.43M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -7.08M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-12 0001564590-14-005554
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -1.94 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-21 0001193125-13-119763
us-gaap IncomeTaxExaminationLiabilityRecorded Income Tax Examination, Liability Recorded (Deprecated 2013-01-31) USD 0 2013-06-30 2013 Q2 10-Q 2013-08-13 0001564590-13-000333
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2015-12-31 2015 FY 10-K 2016-03-17 0001564590-16-014989
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-01 0000950170-24-009809
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097443
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 23.34M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 110,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-14 0001564590-22-010075
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -22.14M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 54,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 107,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-01 0000950170-24-009809
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 949,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -192,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-01 0000950170-24-009809
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 2.11M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 209,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-089246
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD 41,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 5.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap IncreaseDecreaseInDeferredCharges Increase (Decrease) in Deferred Charges USD -2,000 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-12 0001564590-14-005554
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD 9,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-089246
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 961,000 2024-02-06 2024-06-30 2025 Q2 10-Q 2025-08-11 0001213900-25-074281
us-gaap IncreaseDecreaseInNotesReceivableRelatedPartiesCurrent Increase (Decrease) in Notes Receivable, Related Parties, Current USD -1,000 2024-02-06 2024-06-30 2025 Q2 10-Q 2025-08-11 0001213900-25-074281
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -419,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap IncreaseDecreaseInOtherAccountsPayable Increase (Decrease) in Other Accounts Payable USD 10.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD 376,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-089246
us-gaap IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet Increase (Decrease) in Other Current Assets and Liabilities, Net USD 2,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-11 0001564590-15-007020
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 25,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -9,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-22 0001564590-18-006566
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 224,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-11 0001564590-15-007020
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -432,000 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-12 0001564590-14-005554
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 14.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD 1.98M 2024-02-06 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097443
us-gaap InterestAndOtherIncome Interest and Other Income USD 917,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-089246
us-gaap InterestExpense Interest Expense USD 9,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-14 0001564590-22-010075
us-gaap InterestExpenseDebt Interest Expense, Debt USD 1.50M 2024-02-06 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097443
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 1.47M 2024-02-06 2024-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 6,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-22 0001564590-18-006566
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 9,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-14 0001564590-22-010075
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 25.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap InvestmentIncomeInterestAndDividend Investment Income, Interest and Dividend USD 2.02M 2001-12-17 2011-06-30 2011 Q2 10-Q 2011-08-15 0001193125-11-223373
us-gaap InvestmentsAndCash Investments and Cash USD 1.20B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 377,000 2001-12-18 2014-03-31 2014 Q1 10-Q 2014-05-13 0001564590-14-002121
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.18 2025-03-31 2025 Q1 10-Q 2025-05-14 0001213900-25-043279
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 3.39M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 25,000 2021-12-31 2021 FY 10-K 2022-03-14 0001564590-22-010075
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.11M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 25,000 2022-12-31 2022 FY 10-K 2023-02-24 0000950170-23-004379
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 304,000 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 877,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.14M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 257,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 456,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap Liabilities Liabilities USD 33.88M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.23B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap LiabilitiesCurrent Liabilities, Current USD 31.78M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-089246
us-gaap MarketableSecurities Marketable Securities USD 1.02B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 728.76M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap MarketableSecuritiesGainLoss Marketable Securities, Gain (Loss) USD 263,000 2001-12-18 2014-03-31 2014 Q1 10-Q 2014-05-13 0001564590-14-002121
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 286.31M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap NetCashProvidedByUsedInContinuingOperations Net Cash Provided by (Used in) Continuing Operations USD 3.39M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011830
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 830.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 3.42M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011830
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -584.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 3.05M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011830
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -101.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -3.07M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011830
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -122.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -9.69M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-19 0001564590-15-001840
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -2.55M 2012-01-01 2012-06-30 2012 Q2 10-Q 2012-08-13 0001193125-12-352660
us-gaap NoncashOrPartNoncashAcquisitionEmployeeBenefitLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Employee Benefit Liabilities Assumed USD 68,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-13 0001213900-26-055769
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 48,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-22 0001564590-18-006566
us-gaap NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1 Noncash or Part Noncash Acquisition, Other Assets Acquired USD 114,000 2024-02-06 2024-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Other Liabilities Assumed USD 54,000 2024-02-06 2024-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 25.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap NumberOfOperatingSegments Number of Operating Segments pure 1 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-11 0001213900-25-074281
us-gaap NumberOfReportableSegments Number of Reportable Segments Segments 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap OperatingExpenses Operating Expenses USD 148.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -148.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap OperatingLeaseCost Operating Lease, Cost USD 319,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109182
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 800,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 2.93M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 838,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 2.09M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap OperatingLeasePayments Operating Lease, Payments USD 604,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 2.79M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 25,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-089246
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 83,000 2018-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004882
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 83,000 2018-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004882
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 83,000 2016-09-30 2016 Q3 10-Q 2016-11-14 0001564590-16-029259
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 83,000 2017-09-30 2017 Q3 10-Q 2017-11-09 0001564590-17-023278
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 83,000 2018-09-30 2018 Q3 10-Q 2018-11-14 0001564590-18-029560
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 22,000 2018-09-30 2018 Q3 10-Q 2018-11-14 0001564590-18-029560
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 82,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004882
us-gaap OperatingLeaseVariableLeaseIncome Operating Lease, Variable Lease Income USD 300,000 2024-02-06 2024-12-31 2024 FY 10-K 2025-03-06 0001213900-25-021165
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.131 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 208.10M 2023-12-31 2023 FY 10-K 2024-02-01 0000950170-24-009809
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 21.30M 2024-12-31 2024 FY 10-K 2025-03-06 0001213900-25-021165
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 591,000 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-089246
us-gaap OtherAssetsCurrent Other Assets, Current USD 537,000 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-089246
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 128,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD 2,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-18 0001564590-20-005032
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD 2,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-18 0001564590-20-005032
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax USD 212,000 2025-07-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109182
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -5.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap OtherExpenses Other Expenses USD 15.30M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109182
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 440,000 2015-06-30 2015 Q2 10-Q 2015-08-11 0001564590-15-007020
us-gaap OtherNoncashExpense Other Noncash Expense USD 1.47M 2024-02-06 2024-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109182
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -267,000 2001-12-18 2014-03-31 2014 Q1 10-Q 2014-05-13 0001564590-14-002121
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 11,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109182
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 4,000 2024-02-06 2024-12-31 2024 FY 10-K 2025-03-06 0001213900-25-021165
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 17,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap OtherNotesPayable Other Notes Payable USD 800,000 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097443
us-gaap OtherPaymentsToAcquireBusinesses Other Payments to Acquire Businesses USD 1.19M 2001-12-18 2014-03-31 2014 Q1 10-Q 2014-05-13 0001564590-14-002121
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 1.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 1.47M 2024-02-06 2024-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap PayablesToBrokerDealersAndClearingOrganizations Payables to Broker-Dealers and Clearing Organizations USD 1.01M 2016-03-31 2016 Q1 10-Q 2016-05-11 0001564590-16-019116
us-gaap PaymentsForFees Payments for Other Fees USD 800,000 2024-02-06 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097443
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 100,000 2024-02-06 2024-06-30 2025 Q2 10-Q 2025-08-11 0001213900-25-074281
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 1.59M 2024-02-06 2024-06-30 2025 Q2 10-Q 2025-08-11 0001213900-25-074281
us-gaap PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities USD 5.47M 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-11-14 0001564590-18-029560
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 5.47M 2017-01-01 2017-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004882
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 910.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 156,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap PreferredStockAccretionOfRedemptionDiscount Preferred Stock, Accretion of Redemption Discount USD 245,000 2001-12-18 2014-03-31 2014 Q1 10-Q 2014-05-13 0001564590-14-002121
us-gaap PreferredStockDiscountOnShares Preferred Stock, Discount on Shares USD 17,000 2006-12-31 2012 Q3 10-Q 2012-11-13 0001193125-12-467759
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 2.03M 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-19 0001564590-15-001840
us-gaap PreferredStockLiquidationPreference Preferred Stock, Liquidation Preference Per Share USD/shares 0.001 2013-06-04 2013 Q2 10-Q 2013-08-13 0001564590-13-000333
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2023-12-31 2023 FY 10-K 2024-02-01 0000950170-24-009809
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2023-12-31 2023 FY 10-K 2024-02-01 0000950170-24-009809
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2023-12-31 2023 FY 10-K 2024-02-01 0000950170-24-009809
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2023-12-31 2023 FY 10-K 2024-02-01 0000950170-24-009809
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 21.22M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 10.84M 2001-12-17 2012-03-31 2012 Q1 10-Q 2012-05-14 0001193125-12-231528
us-gaap ProceedsFromIncomeTaxRefunds Proceeds from Income Tax Refunds USD 9,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-14 0001564590-22-010075
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 10.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 2.93M 2024-02-06 2024-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 20.00M 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-19 0001564590-15-001840
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 188.68M 2024-02-06 2024-12-31 2024 FY 10-K 2025-03-06 0001213900-25-021165
us-gaap ProceedsFromIssuanceOfRedeemablePreferredStock Proceeds from Issuance of Redeemable Preferred Stock USD 38,000 2001-12-17 2013-03-31 2013 Q1 10-Q 2013-05-13 0001564590-13-000015
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 14,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-089246
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 100,000 2024-02-06 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097443
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 24.98M 2024-02-06 2024-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD 227.95M 2024-02-06 2024-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 3.05M 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-18 0001564590-20-005032
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 326.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap ProceedsFromSaleOfIntangibleAssets Proceeds from Sale of Intangible Assets USD 2.00M 2001-12-18 2014-03-31 2014 Q1 10-Q 2014-05-13 0001564590-14-002121
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 358,000 2001-12-18 2014-03-31 2014 Q1 10-Q 2014-05-13 0001564590-14-002121
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 337,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -30.28M 2025-07-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109182
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 222,000 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-089246
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 309,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty Related Party Transaction, Expenses from Transactions with Related Party USD 108,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-04-24 0000950170-23-014091
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 105,000 2001-12-18 2014-03-31 2014 Q1 10-Q 2014-05-13 0001564590-14-002121
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 4.00M 2001-12-18 2014-03-31 2014 Q1 10-Q 2014-05-13 0001564590-14-002121
us-gaap RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths Repayments of Short-term Debt, Maturing in More than Three Months USD 408,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-14 0001564590-22-010075
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 126.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminated Restructuring and Related Cost, Number of Positions Eliminated Employee 12 2022-01-01 2022-12-31 2023 FY 10-K 2024-02-01 0000950170-24-009809
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.67 2022-01-01 2022-12-31 2023 FY 10-K 2024-02-01 0000950170-24-009809
us-gaap RestructuringCharges Restructuring Charges USD 2.41M 2001-12-18 2014-03-31 2014 Q1 10-Q 2014-05-13 0001564590-14-002121
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 0 2023-12-31 2024 Q2 10-Q 2024-08-01 0000950170-24-089246
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -312.15M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap Revenues Revenues USD 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-089246
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 1.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 3.04M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-12 0001564590-14-005554
us-gaap SeveranceCosts1 Severance Costs USD 159,000 2023-01-01 2023-12-31 2024 Q2 10-Q 2024-08-01 0000950170-24-089246
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 23.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding USD 51.04M 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097443
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 400 2017-01-01 2017-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004882
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 6.03 2017-01-01 2017-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004882
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 3.05M 2024-02-06 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097443
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 7.8 2024-02-06 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097443
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 3.05M 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097443
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 7.8 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097443
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 3.05M 2024-02-06 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097443
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 51.04M 2024-02-06 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097443
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 7.8 2024-02-06 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097443
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2022-01-01 2022-12-31 2023 FY 10-K 2024-02-01 0000950170-24-009809
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.99 2024-02-06 2024-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.042 2024-02-06 2024-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 54,387 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-21 0001193125-13-119763
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 1.16M 2013-12-31 2013 FY 10-K 2014-03-20 0001564590-14-000934
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 108.91M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.57M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 14.1 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-22 0001564590-18-006566
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 100,815 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 10.05 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-089246
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value USD/shares 0 2024-02-06 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097443
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.87 2022-01-01 2022-12-31 2023 FY 10-K 2024-02-01 0000950170-24-009809
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 315.09M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 5.20M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 23.12 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 315.09M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 18,000 2022-12-31 2022 FY 10-K 2023-02-24 0000950170-23-004379
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 5.20M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 23.12 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 14.03 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 16.59 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 42.76 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 4.38 2014-12-31 2014 FY 10-K 2015-03-19 0001564590-15-001840
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 494,291 2014-12-31 2014 FY 10-K 2015-03-19 0001564590-15-001840
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 1.07M 2014-12-31 2014 FY 10-K 2015-03-19 0001564590-15-001840
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price USD/shares 2.89 2014-12-31 2014 FY 10-K 2015-03-19 0001564590-15-001840
us-gaap SharesPaidForTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation shares 0 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-22 0001564590-18-006566
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 1.20B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap StockholdersEquityNoteStockSplitConversionRatio Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31) pure 0.167 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-21 0001193125-13-119763
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.143 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-09 0001564590-16-023718
us-gaap StockholdersEquityOther Stockholders' Equity, Other USD 10,000 2019-10-01 2019-12-31 2020 Q3 10-Q 2020-11-02 0001564590-20-049656
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 496,066 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 11.91M 2009-01-01 2009-12-31 2014 Q1 10-Q 2014-05-13 0001564590-14-002121
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 25.00M 2024-02-06 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097443
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 26.45M 2024-02-07 2024-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan Stock Issued During Period, Value, Employee Stock Ownership Plan USD 2,000 2009-01-01 2009-12-31 2014 Q1 10-Q 2014-05-13 0001564590-14-002121
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 337,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap StockIssuedDuringPeriodValueIssuedForCash Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) USD 280,000 2012-10-01 2012-10-25 2012 Q3 10-Q 2012-11-13 0001193125-12-467759
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 122.48M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-18 0001564590-20-005032
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 243,000 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-13 0001193125-12-467759
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 4.29M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001213900-26-117518
us-gaap TenantReimbursements Tenant Reimbursements (Deprecated 2018-01-31) USD 593,000 2008-02-01 2008-02-08 2013 Q2 10-Q 2013-08-13 0001564590-13-000333
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 1.82M 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 123,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 895,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD 91,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 27.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001213900-26-026929
us-gaap VariableLeaseCost Variable Lease, Cost USD 600,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109182
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 8.20M 2013-09-30 2013 Q3 10-Q 2013-11-13 0001564590-13-001316
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 2,188 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-19 0001564590-15-001840
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 41.89M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-11 0001213900-25-074281
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 14.41M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-02 0001564590-22-017043
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 20.50M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-19 0001564590-15-001840
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 41.89M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-11 0001213900-25-074281

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →